Human steroidogenesis: Implications for controlled ovarian stimulation with exogenous gonadotropins

Reproductive Biology and Endocrinology

Volumn 12, Issue 1, 2014, Pages

  Andersen, Claus Y ^a   Ezcurra, Diego ^b  

^a Mental Health Services CPH   (Denmark)

^b Global Medical Affairs EMD Merck Serono One Technology Place   (United States)

Author keywords

Controlled ovarian stimulation; Gonadotropins; Luteinising hormone; Progesterone elevation; Steroidogenesis

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CYTOCHROME P450; CYTOCHROME P450 11A; CYTOCHROME P450 17; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; PRASTERONE; PREGNENOLONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; SOMATOMEDIN B; SOMATOMEDIN C; STEROID; UNCLASSIFIED DRUG; RECOMBINANT PROTEIN;

ADRENAL GLAND; CONTROLLED OVARIAN STIMULATION; DRUG EFFECT; EMBRYO TRANSFER; ENDOMETRIUM; ENZYME ACTIVITY; ENZYME SYNTHESIS; FERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GRANULOSA CELL; HORMONAL REGULATION; HORMONE METABOLISM; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MENSTRUAL CYCLE; MULTICENTER STUDY (TOPIC); NIDATION; NONHUMAN; OOCYTE RETRIEVAL; OVARY; OVARY FOLLICLE; OVARY FOLLICLE FLUID; OVARY FUNCTION; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEROIDOGENESIS; THECA CELL; ADVERSE EFFECTS; AGONISTS; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECTS; ENZYMOLOGY; EVIDENCE BASED MEDICINE; FEMALE; GENETICS; INFERTILITY, FEMALE; METABOLISM; OVULATION; PROCEDURES;

ANIMALS; EVIDENCE-BASED MEDICINE; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; MODELS, BIOLOGICAL; OVARY; OVULATION; OVULATION INDUCTION; PROGESTERONE; RECOMBINANT PROTEINS;

EID: 84927626115     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-12-128     Document Type: Review

References (53)

1. Bourgain C, Devroey P: The endometrium in stimulated cycles for IVF. Hum Reprod Update 2003, 9:515-522. 10.1093/humupd/dmg045.
2. Horcajadas JA, Mínguez P, Dopazo J, Esteban FJ, Domínguez F, Giudice LC, Pellicer A, Simón C: Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications. J Clin Endocrinol Metab 2008, 93:4500-4510. 10.1210/jc.2008-0588.
3. Sullivan MW, Stewart-Akers A, Krasnow JS, Berga SL, Zeleznik AJ: Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation. J Clin Endocrinol Metab 1999, 84:228-232.
4. Jeppesen JV, Kristensen SG, Nielsen ME, Humaidan P, Dal Canto M, Fadini R, Schmidt KT, Ernst E, Yding Andersen C: LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. J Clin Endocrinol Metab 2012, 97:E1524-E1531. 10.1210/jc.2012-1427.
5. Conti M: Specificity of the cyclic adenosine 3',5'-monophosphate signal in granulosa cell function. Biol Reprod 2002, 67:1653-1661. 10.1095/biolreprod.102.004952.
6. Tonetta SA, diZerega GS: Intragonadal regulation of follicular maturation. Endocr Rev 1989, 10:205-229. 10.1210/edrv-10-2-205.
7. Howles CM, Loumaye E, Giroud D, Luyet G: Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study. Hum Reprod 1994, 9:424-430.
8. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT, Pocognoli P: Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 1999, 84:2659-2663.
9. Fukuda S, Orisaka M, Tajima K, Hattori K, Kotsuji F: Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells. J Ovarian Res 2009, 16:2-17.
10. Yong EL, Hillier SG, Turner M, Baird DT, Ng SC, Bongso A, Ratnam SS: Differential regulation of cholesterol side-chain cleavage (P450scc) and aromatase (P450arom) enzyme mRNA expression by gonadotrophins and cyclic AMP in human granulosa cells. J Mol Endocrinol 1994, 12:239-249. 10.1677/jme.0.0120239.
11. Miller WL: Steroidogenic enzymes. Endocr Dev 2008, 13:1-18.
12. Wickenheisser JK, Nelson-DeGrave VL, McAllister JM: Human ovarian theca cells in culture. Trends Endocrinol Metab 2006, 17:65-71. 10.1016/j.tem.2006.01.003.
13. Smyth CD, Miró F, Whitelaw PF, Howles CM, Hillier SG: Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology 1993, 133:1532-1538.
14. Whitelaw PF, Smyth CD, Howles CM, Hillier SG: Cell-specific expression of aromatase and LH receptor mRNAs in rat ovary. J Mol Endocrinol 1992, 9:309-312. 10.1677/jme.0.0090309.
15. Young JM, McNeilly AS: Theca: the forgotten cell of the ovarian follicle. Reproduction 2010, 140:489-504. 10.1530/REP-10-0094.
16. Andersen CY: Possible new mechanism of cortisol action in female reproductive organs: physiological implications of the free hormone hypothesis. J Endocrinol 2002, 173:211-217. 10.1677/joe.0.1730211.
17. Pandey AV, Miller WL: Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem 2005, 280:13265-13271. 10.1074/jbc.M414673200.
18. Auchus RJ, Lee TC, Miller WL: Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 1998, 273:3158-3165. 10.1074/jbc.273.6.3158.
19. Nahum R, Thong KJ, Hillier SG: Metabolic regulation of androgen production by human thecal cells in vitro. Hum Reprod 1995, 10:75-81. 10.1093/humrep/10.1.75.
20. McAllister JM, Byrd W, Simpson ER: The effects of growth factors and phorbol esters on steroid biosynthesis in isolated human theca interna and granulosa-lutein cells in long term culture. J Clin Endocrinol Metab 1994, 79:106-112.
21. Spicer LJ, Aad PY, Allen DT, Mazerbourg S, Payne AH, Hsueh AJ: Growth differentiation factor 9 (GDF9) stimulates proliferation and inhibits steroidogenesis by bovine theca cells: influence of follicle size on responses to GDF9. Biol Reprod 2008, 78:243-253. 10.1095/biolreprod.107.063446.
22. Fournet N, Weitsman SR, Zachow RJ, Magoffin DA: Transforming growth factor-beta inhibits ovarian 17 alpha-hydroxylase activity by a direct noncompetitive mechanism. Endocrinology 1996, 137:166-174.
23. Dooley CA, Attia GR, Rainey WE, Moore DR, Carr BR: Bone morphogenetic protein inhibits ovarian androgen production. J Clin Endocrinol Metab 2000, 85:3331-3337. 10.1210/jcem.85.9.6835.
24. DeMoura MD, Choi D, Adashi EY: Insulin-like growth factor-I-mediated amplification of follicle-stimulating hormone-supported progesterone accumulation by cultured rat granulosa cells: enhancement of steroidogenic enzyme activity and expression. Biol Reprod 1997, 56:946-953. 10.1095/biolreprod56.4.946.
25. Eimerl S, Orly J: Regulation of steroidogenic genes by insulin-like growth factor-1 and follicle-stimulating hormone: differential responses of cytochrome P450 side-chain cleavage, steroidogenic acute regulatory protein, and 3beta-hydroxysteroid dehydrogenase/isomerase in rat granulosa cells. Biol Reprod 2002, 67:900-910. 10.1095/biolreprod.101.002170.
26. Payne AH, Hales DB: Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004, 25:947-970. 10.1210/er.2003-0030.
27. Westergaard L, Christensen IJ, McNatty KP: Steroid levels in ovarian follicular fluid related to follicle size and health status during the normal menstrual cycle in women. Hum Reprod 1986, 1:227-232.
28. Fleming R, Jenkins J: The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles. Reprod Biomed Online 2010, 21:446-449. 10.1016/j.rbmo.2010.05.018.
29. Schneyer AL, Fujiwara T, Fox J, Welt CK, Adams J, Messerlian GM, Taylor AE: Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations. J Clin Endocrinol Metab 2000, 85:3319-3330.
30. Coutts JRT (Ed): Functional morphology of the human ovary. Lancaster: MTP; 1981.
31. Bungum L, Jacobsson AK, Rosén F, Becker C, Yding Andersen C, Güner N, Giwercman A: Circadian variation in concentration of anti-Müllerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels. Hum Reprod 2011, 26:678-684. 10.1093/humrep/deq380.
32. Cédrin-Durnerin I, Bulwa S, Hervé F, Martin-Pont B, Uzan M, Hugues JN: The hormonal flare-up following gonadotrophin-releasing hormone agonist administration is influenced by a progestogen pretreatment. Hum Reprod 1996, 11:1859-1863. 10.1093/oxfordjournals.humrep.a019507.
33. Ubaldi F, Camus M, Smitz J, Bennink HC, Van Steirteghem A, Devroey P: Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 1996, 66:275-280.
34. Beckers NG, Laven JS, Eijkemans MJ, Fauser BC: Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization. Hum Reprod 2000, 15:43-49.
35. Smitz J, Andersen AN, Devroey P, Arce JC: MERIT Group: Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod 2007, 22:676-687.
36. Andersen AN, Devroey P, Arce JC: Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 2006, 21:3217-3227. 10.1093/humrep/del284.
37. Out HJ, Rutherford A, Fleming R, Tay CC, Trew G, Ledger W, Cahill D: A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction. Hum Reprod 2004, 19:90-95. 10.1093/humrep/deh044.
38. Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J, Pellicer A: Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod 2010, 25:2092-2100. 10.1093/humrep/deq125.
39. Thuesen LL, Loft A, Egeberg AN, Smitz J, Petersen JH, Nyboe Andersen A: A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. Hum Reprod 2012, 27:3074-3084. 10.1093/humrep/des256.
40. Thuesen LL, Smitz J, Loft A, Nyboe Andersen A: Endocrine effects of hCG supplementation to recombinant FSH throughout controlled ovarian stimulation for IVF: a dose-response study. Clin Endocrinol (Oxf) 2013, 79:708-715.
41. Devroey P, Pellicer A, Andersen AN, Arce JC, On behalf of the Menopur in GnRH Antagonist Cycles with Single Embryo Transfer (MEGASET) Trial Group: A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer. Fertil Steril 2012, 97:561-571. 10.1016/j.fertnstert.2011.12.016.
42. Requena A, Cruz M, Ruiz FJ, Garcia-Velasco JA: Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin. Reprod Biol Endocrinol 2014, 12:10. doi:10.1186/1477-7827-12-10 10.1186/1477-7827-12-10.
43. Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B: High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Hum Reprod 2013, 28:442-452. 10.1093/humrep/des389.
44. Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM, Gordon K: Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertil Steril 2013, 100:1622-1628. 10.1016/j.fertnstert.2013.08.045.
45. Nyboeandersen A, Humaidan P, Fried G, Hausken J, Antila L, Bangsbøll S, Rasmussen PE, Lindenberg S, Bredkjaer HE, Meinertz H, Nordic LH study group: Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. Hum Reprod 2008, 23:427-434.
46. Andersen CY, Bungum L, Andersen AN, Andersen CY: High late follicular phase serum progesterone levels during controlled ovarian stimulation have no impact on pregnancy rates and are not influenced by exogenous LH. Reprod Biomed Online 2011, 23:187-195. 10.1016/j.rbmo.2011.04.003.
47. Strauss S, Greve T, Ernst E, Fraidakis M, Grudzinskas JG, Andersen CY: Administration of DHEA augments progesterone production in a woman with low ovarian reserve being transplanted with cryopreserved ovarian tissue. J Assist Reprod Genet 2014, 31:645-649. 10.1007/s10815-014-0214-3.
48. Wolfenson D, Sonego H, Shaham-Albalancy A, Shpirer Y, Meidan R: Comparison of the steroidogenic capacity of bovine follicular and luteal cells, and corpora lutea originating from dominant follicles of the first or second follicular wave. J Reprod Fertil 1999, 117:241-247. 10.1530/jrf.0.1170241.
49. Fleming R: Progesterone elevation on the day of hCG: methodological issues. Hum Reprod Update 2008, 14:391-392. 10.1093/humupd/dmn019.
50. Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC: Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2007, 13:343-355. 10.1093/humupd/dmm007.
51. Bosch E: Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al. (2007). Hum Reprod Update 2008, 14:194-195. 10.1093/humupd/dmm046.
52. Coucke W, Devleeschouwer N, Libeer JC, Schiettecatte J, Martin M, Smitz J: Accuracy and reproducibility of automated estradiol-17beta and progesterone assays using native serum samples: results obtained in the Belgian external assessment scheme. Hum Reprod 2007, 22:3204-3209. 10.1093/humrep/dem322.
53. Andersen CY, Morineau G, Fukuda M, Westergaard LG, Ingerslev HJ, Fiet J, Byskov AG: Assessment of the follicular cortisol: cortisone ratio. Hum Reprod 1999, 14:1563-1568. 10.1093/humrep/14.6.1563.